Centre for Urological Research

2004 Publications

Local aromatase expression in human prostate is altered in malignancy. Ellem SJ, Schmitt JF, Pedersen JS, Frydenberg M, Risbridger GP. J. Clin. Endocrinol. Metab. 89 (5), 2434-41. Abstract

Hormonal, cellular, and molecular regulation of normal and neoplastic prostatic development.
Cunha GR, Ricke W, Thomson A, Marker PC, Risbridger G, Hayward SW, Wang YZ, Donjacour AA, Kurita T. J Steroid Biochem Mol Biol. Nov;92(4):221-36. Epub 2004 Dec 21. Review. Abstract

Re-evaluation of inhibin alpha subunit as a tumour suppressor in prostate cancer. Risbridger GP, Ball EM, Wang H, Mellor SL, Peehl DM. Mol Cell Endocrinol. Oct 15;225(1-2):73-6. Abstract

Cancer progression: is inhibin alpha from Venus or Mars? Ball EM, Mellor SL, Risbridger GP. Cytokine Growth Factor Rev. Oct;15(5):291-6. Review. Abstract

Cell-specific expression of betaC-activin in the rat reproductive tract, adrenal and liver. Gold EJ, O'Bryan MK, Mellor SL, Cranfield M, Risbridger GP, Groome NP, Fleming JS. Mol Cell Endocrinol. Jul 30;222(1-2):61-9.Abstract

Role of estrogens in the male reproductive tract. Simpson ER, McPherson S, Jones M, Robertson K, Boon WC, Risbridger G.Ernst Schering Res Found Workshop. (46):89-112. (Abstract currently unavailable.)

Searching the Internet for information on prostate cancer screening: an assessment of quality.
Ilic D, Risbridger G, Green S. Urology. Jul;64(1):112-6. Abstract

Epigenetic regulation of inhibin alpha-subunit gene in prostate cancer cell lines. Balanathan P, Ball EM, Wang H, Harris SE, Shelling AN, Risbridger GP. J Mol Endocrinol. Feb;32(1):55-67. Abstract

Elevated expression of inhibin alpha in prostate cancer. Risbridger GP, Shibata A, Ferguson KL, Stamey TA, McNeal JE, Peehl DM. J Urol. Jan;171(1):192-6. Abstract